Literature DB >> 20852855

Adrenal and renal corticomedullary junction iron deposition in red cell aplasia.

Rebecca Rakow-Penner1, Bert Glader, Huanzhou Yu, Shreyas Vasanawala.   

Abstract

Iron deposition can occur in the kidneys as a result of hemolysis or extensive iron overload from transfusions. With T2* MRI, renal iron deposition can be visualized. In this report, renal corticomedullary junction iron deposition is noted using T2* MRI in a boy with red cell aplasia. The renal corticomedullary junction iron deposition is an indication of the severity of his iron overload. This is an unusual finding and brings clinical attention to the boy's renal function for further evaluation.

Entities:  

Mesh:

Year:  2010        PMID: 20852855     DOI: 10.1007/s00247-010-1824-2

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

Review 1.  Secondary iron overload.

Authors:  J P Kushner; J P Porter; N F Olivieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

2.  The kidney in paroxysmal nocturnal haemoglobinuria: MRI findings.

Authors:  J Rimola; J Martín; J Puig; A Darnell; A Massuet
Journal:  Br J Radiol       Date:  2004-11       Impact factor: 3.039

3.  Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias.

Authors:  Sarah Deborah Chirnomas; Marnix Geukes-Foppen; Kristen Barry; Jennifer Braunstein; Leslie A Kalish; Ellis J Neufeld; Andrew J Powell
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

4.  Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation.

Authors:  Huanzhou Yu; Charles A McKenzie; Ann Shimakawa; Anthony T Vu; Anja C S Brau; Philip J Beatty; Angel R Pineda; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

5.  Sickle-cell nephropathy: MR imaging.

Authors:  I M Lande; G M Glazer; S Sarnaik; A Aisen; D Rucknagel; W Martel
Journal:  Radiology       Date:  1986-02       Impact factor: 11.105

6.  R2* magnetic resonance imaging of the liver in patients with iron overload.

Authors:  Jane S Hankins; M Beth McCarville; Ralf B Loeffler; Matthew P Smeltzer; Mihaela Onciu; Fredric A Hoffer; Chin-Shang Li; Winfred C Wang; Russell E Ware; Claudia M Hillenbrand
Journal:  Blood       Date:  2009-03-04       Impact factor: 22.113

7.  Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis.

Authors:  Aaron Schein; Cathleen Enriquez; Thomas D Coates; John C Wood
Journal:  J Magn Reson Imaging       Date:  2008-09       Impact factor: 4.813

8.  Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major.

Authors:  Olympia Papakonstantinou; Efthymia Alexopoulou; Nikos Economopoulos; Odysseas Benekos; Antonis Kattamis; Stavroula Kostaridou; Vasilis Ladis; Efstathios Efstathopoulos; Athanassios Gouliamos; Nikolaos L Kelekis
Journal:  J Magn Reson Imaging       Date:  2009-04       Impact factor: 4.813

  8 in total
  3 in total

Review 1.  Iron metabolism in the pathogenesis of iron-induced kidney injury.

Authors:  A M F Martines; R Masereeuw; H Tjalsma; J G Hoenderop; J F M Wetzels; D W Swinkels
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

2.  Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Behjat Alsaadat Moaeidi; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Hamid Nasri; Shahrzad Baradaran; Marjan Gharagozloo; Tahereh Safari; Maryam Haghighi
Journal:  Int J Prev Med       Date:  2013-03

3.  Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model.

Authors:  Mitra Navidi-Shishaone; Soheila Mohhebi; Mehdi Nematbakhsh; Shahla Roozbehani; Ardeshir Talebi; Zahra Pezeshki; Fatemeh Eshraghi-Jazi; Safoora Mazaheri; Sohiela Shirdavani; Marjan Gharagozloo; Behjat Alsaadat Moaeidi
Journal:  Int J Prev Med       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.